XTLB
XTL Biopharmaceuticals Ltd ADR
NASDAQ: XTLB · HEALTHCARE · BIOTECHNOLOGY
$3.90
+9.55% today
Updated 2026-04-30
Market cap
$5.65M
P/E ratio
—
P/S ratio
5.84x
EPS (TTM)
$-3.60
Dividend yield
—
52W range
$2 – $10
Volume
2.3M
XTL Biopharmaceuticals Ltd ADR (XTLB) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+92.3%
Most recent quarter
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-13.8%
Last 1 reports
Positive reaction rate
0%
0 of 1 quarters
Largest single-day move
-13.8%
2025-12-30
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-12-30 | $-0.01 | — | $0.67 | $0.58 | -13.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-09-30 | $0.00 | $-0.01 | — | — | — |
| 2025-03-31 | $0.00 | $0.00 | — | $289000.00 | — |
| 2024-12-31 | — | $-0.12 | — | $289000.00 | — |
| 2024-09-30 | — | $-0.04 | — | $162000.00 | — |
| 2024-06-30 | — | $-0.13 | — | — | — |
| 2024-03-31 | — | $0.09 | — | — | — |
| 2023-12-31 | $0.00 | $-0.05 | — | — | — |
| 2023-09-30 | $0.00 | $-0.04 | — | — | — |
| 2023-06-30 | $0.00 | $-0.07 | — | — | — |
| 2023-03-31 | $0.00 | $-0.17 | — | — | — |
| 2022-12-31 | $0.00 | $-0.14 | — | $-459000.00 | — |
| 2022-09-30 | $0.00 | $-0.15 | — | — | — |
Frequently asked questions
Has XTL Biopharmaceuticals Ltd ADR beaten earnings estimates?
XTL Biopharmaceuticals Ltd ADR has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports.
How does XTLB stock react to earnings?
XTLB stock has moved an average of -13.8% in the trading day following earnings over its last 1 reports, with positive reactions in 0% of those quarters.